Additionally, compared to that in control cells, the activity of a VEGF-C promoter that contains a NF-κB binding site was significantly increased in Bmi-1-overexpressing but markedly decreased in Bmi-1-silenced glioma cells. This evidence concerns the gene VEGFC and central nervous system cancer.